Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Longevity Healthcare Center, San Luis Obispo, CA, USA.
Tissue mercury levels in humans have increased during the past 50 years to an alarming concentration, with possible deleterious effects that may involve neurological, cardiovascular, and immunological pathology. This article reviews the protocol for the use of oral 2,3-dimercaptopropane-1-sulfonate (DMPS) and oral meso-2, 3-dimercaptosuccinic acid (DMSA) in combination with intravenous glutathione and high-dose vitamin C for treatment of high-level mercury. This protocol yielded an average 69% reduction of urine mercury by provocation analysis.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on